|
EVOK | Evoke Pharma Inc |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.09 |
| Leverage | 78.52% |
| Market Cap | $ 36.8m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -5.2m |
| Margin | -36.38% |
Evoke Pharma, Inc., a specialty pharmaceutical company, focuses primarily on the development and commercialization of drugs for the treatment of gastroenterological diseases and disorders. The company is headquartered in Solana Beach, California.